From Medscape Infectious Diseases

Coverage from the

Infectious Disease Week (IDWeek) 2021 Annual Meeting

September 29 - October 03, 2021; Virtual

September 29 - October 03, 2021 Virtual
  • IDWeek 2021 Oteseconazole Promising for Recurrent Yeast Infections A phase 3 trial indicates the drug is safe and effective in treating acute and recurrent cases of acute vulvovaginal candidiasis, and preventing recurrence of VVC episodes.

Conference News

Popular News from IDWeek 2020

Medscape Infectious Diseases© WebMD, LLC

Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.

Previous Coverage